Today, 13.00-13.45, Clinical Laserthermia Systems CEO Dan Mogren and CFO Håkan Rosqvist will present...
Analyst Group inleder idag den 21:e februari 2024 analysbevakning på Cedergrenska AB (”Cedergrenska”...
Sales SEK 432m +3% vs. ABGSCe 419m EBIT better than expected Consensus EBIT estimate revisions likel...
Redeye comments on Binero IT’s H2-24 results. Sales were SEK212m in the second half of the year, rep...
Redeye saw a sales development that was just below our expectations.
Net sales and clean EBIT were close to market consensus (LSEG) in Q4.
We upgrade our Q4 EBIT forecast slightly, due to 18% y/y growth in cargo vessel calls.
Redeyes’ long-term view of Dignitana continues to be positive.
Redeye updates on Better Collective following its Q4-results and guidance for 2025.
Redeye updates its estimates and valuation following Navigo releasing its Q4 2024 report.
Ferronordic reported a mixed set of Q4 2024 numbers, with sales clearly beating our expectation, lar...
Next milestones: finalisation of environmental permit.
Germany weaker than expected, US stronger We make more cuts in Germany High leverage is the bottlene...
We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at...
Aktiemarknaden verkar ha haft högre förväntningar med tanke på dagens kursreaktion, men ur vårt pers...
